Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein ai gene: Clinical and pathological features

American Journal of Gastroenterology

Volumn 96, Issue 6, 2001, Pages 1872-1876

  Parikh, Ameet ^b   Ramamoorthy, Ravishankar ^b   Kim, Kyung H ^b   Holland, Bart K ^b   Houghton, JeanMarie ^a,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b JERSEY CITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; APOLIPOPROTEIN A1; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AMYLOIDOSIS; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; FAMILIAL DISEASE; FATALITY; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; JAUNDICE; LIVER BIOPSY; LIVER DISEASE; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL;

ADULT; ALKALINE PHOSPHATASE; AMYLOIDOSIS; APOLIPOPROTEIN A-I; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; MUTATION;

EID: 0034972196     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02450-9     Document Type: Article

References (33)

1. Amyloidosis
2. Actualización de la amiloidosis. Amiloidosis hereditarias
3. Transthyretin and familial amyloidotic polyneuropathy
4. Familial nephropatic systemic amyloidosis caused by apolipoprotein AI variant Arg26
5. A new apolipoprotein AI variant, Trp50Arg, causes hereditary amyloidosis
6. Human lysozyme gene mutations cause hereditary systemic amyloidosis
7. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene
8. Hereditary renal amyloidosis with a novel variant of fibrinogen
9. 123I serum amyloid P component scintigraphy in 484 patients
10. Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene
11. 123I-labeled serum amyloid P component
12. On the binding of Congo red by amyloid
13. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
14. Hepatic amyloidosis: Morphologic differences between systemic AL and AA types
15. Hepatic amyloidosis: Clinical appraisal in 77 patients
16. Amyloidosis (AL). Clinical and laboratory features in 229 patients
17. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): The natural history in 80 patients
18. Primary amyloidosis and severe intrahepatic cholestasis
19. Amyloid depositon in intrahepatic large bile ducts and peribiliary glands in systemic amyloidosis
20. The systemic amyloidoses
21. Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE 122)
22. Familial amyloidosis of Ostertag
23. Familial renal amyloidosis: Case reports and genetic studies
24. Case records of the Massachusetts General Hospital (Case 50-1987)
25. Variant apolipoprotein Al as a major constituent of human hereditary amyloid
26. Familial nephropathic non-neuropathic amyloidosis: Clinical features, immunohistochemistry and chemistry
27. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis
28. Sinuosidal portal hypertension in hepatic amyloidosis
29. 30)
30. Liver transplantation as a treatment for familial amyloidotic polyneuropathy
31. World-wide survey of liver transplantation in patients with familial amyloidotic polyneuropathy
32. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis
33. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation